Semiconductors Weekly: Semis Flat on 6% Cuts - Moore Stress Beneficiaries Outperforming

Size: px
Start display at page:

Download "Semiconductors Weekly: Semis Flat on 6% Cuts - Moore Stress Beneficiaries Outperforming"

Transcription

1 INDUSTRY NOTE USA Weekly: Semis Flat on 6% Cuts - Moore Stress Beneficiaries Outperforming Key Takeaway Data from 37 semiconductor earnings reports shows that at the median, semis lowered 4Q revenue expectations by 6%, but stock prices remained flat the day after reporting, and also since reporting. Stocks we identified as Moore Stress beneficiaries appreciated since reporting (,, ),, while stocks we think challenged by Moore Stress declined (, ). Semis Staying Flat on Cuts: Of the 37 semiconductor companies that have reported so far, 31 have lowered 4Q revenue expectations. At the median, 4Q revenue expectations have been cut by 6%, but semi stocks remained flat the day after reporting, as well as since reporting. We think this means bad news is baked in, but there is little optimism for an imminent turnaround. Moore Stress Evidence? There were several datapoints that we think are consistent with our Moore Stress thesis since we published it on Sep 26: 1) ASML announced its intention to acquire CYMI for a substantial premium, we think in an attempt to accelerate the development of EUV lithography tools, 2) on its earnings call, CEO posited that cost per transistor on 20nm would not likely decline, and 3) announced that it lost three high-volume sockets to ASICs. None is proof of our Moore Stress thesis, but all three are consistent with our view that cost per transistor is inflecting on leading edge nodes, and is impacting the industry today. EQUITY RESEARCH AMERICAS Moore Stress Beneficiaries Outperforming: Stocks we identified as Moore Stress beneficiaries appreciated since reporting 3Q12 results -,, and appreciated by 5%, 4%, 15% and 8%. Conversely, stocks we identified as being challenged by Moore Stress declined - and have declined by 3% and 7%. We remain buyers of Moore Stress beneficiaries,,,, and. Moore Stress Related Notes: /24/2012: Takeaways from "Moore Stress" Conf Call w/ Dr. Handel Jones /11/2012: Moore Feedback - EUV Push? 9/26/2012: Moore Stress = Structural Industry Shift Mark Lipacis * Equity Analyst (415) mlipacis@jefferies.com Sundeep Bajikar * Equity Analyst (415) sbajikar@jefferies.com Jonnathan Lee * Equity Associate (415) jlee@jefferies.com * Jefferies & Company, Inc. Jefferies does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see analyst certifications, important disclosure information, and information regarding the status of non-us analysts on pages 11 to of this report.

2 Semis Flat On Cuts Chart 1 shows a list of 37 semiconductor companies that have reported 3Q earnings, as well as how much they lowered 4Q revenue expectations, and how the stocks performed one day after reporting, and since reporting as of last Friday. At the median, semiconductor stocks lowered 4Q revenue expectations by 600 bps, and stayed flat the day after reporting, and also flat as of last Friday (/26/2012). Chart 1 shows 37 semiconductor companies that have reported 3Q results. At the median, semis lowered 4Q revenue expectations by 600 bps, and then saw their stocks flat the day after reporting. We believe this indicates that semiconductor stocks are already discounting worse fundamentals than are being reported. Chart 1: Revision of 4Q Guidance and Stock Performance Stock Earnings Date 4Q Rev Guidance vs. Consensus Stock Performance On Day After Stock Performance Since Reporting RFMD /23/ SLAB /24/12 4% - - TQNT /24/12-13% -13% AMCC /25/12 25% 26% EXAR /24/12 8% 9% /18/12 3% - HITT /25/12 - CREE /17/12-3% /16/ % - ENTR /24/ /25/12-5% 5% POWI /25/12-6% 5% STM /23/12-3% 4% FSL /25/12-3% 3% /18/12-4% 5% 8% /23/12-4% -3% -5% CY /18/12-6% -4% - MLNX /17/12-6% -2-25% /25/12-6% 15% 15% /17/12-6% - -3% AMKR /25/12-6% - - MCRL /25/12-8% /23/12-8% -8% -7% /22/12-8% 4% LRCX /17/12-8% 7% 5% /16/12-8% - -3% CODE /25/12 -% ISIL /24/12 -% 8% 8% INVN /23/12 -% -7% -1 FCS /18/ % -4% GSIT /25/ % -5% /18/ % -2 ASML /17/12-13% 8% VLTR /22/12 -% MKSI /24/12-15% -3% - KLAC /25/12-16% - TER /24/12-28% 8% 6% Median -6% Source: Jefferies, CapIQ page 2 of

3 NDX/SOX Ratio SOX/SPX (Relative Performance) Oct-99 Oct-01 Oct-00 Oct-02 Oct-01 Oct-03 Oct-02 Oct-04 Oct-03 Oct-05 Oct-04 Oct-05 Oct-06 Oct-06 Oct-07 Oct-07 Oct-08 Oct-08 Oct-09 Oct-09 Oct- Oct- Oct-11 Oct-11 Oct-12 Oct-12 SOX Index Semis NTM Earnings Forecast Ex- ($,bn) The SOX underperformed the SPX by 2bps over the past week, and underperformed by 340 bps over the past four weeks. Semis outperforming once estimate cuts start is consistent with historical stock behavior. Semiconductor stocks typically underperform 3-4 months in front of estimate cuts, and outperform shortly after consensus starts cutting estimates. Semis have underperformed materially over the past 4 months, we think in anticipation of the cuts that are happening now. Chart 5: Semis NTM Earnings Forecast vs. Relative Performance SOX/SPX Consensus NTM Earnings Forecast Vertical lines represent start of earnings cuts Semis started to underperform at the end of Jan '12, anticipating cuts that started in May '12. Cuts started May ' Source: Jefferies and Capital IQ SOX is above historical level of maximum negativity Chart 6: SOX vs. NDX/SOX 12 SOX bottomed at 370 on 04/30/99 and ran 26 trough-to-peak SOX SOX bottomed at on 08/31/ and ran 54% trough-to-peak SOX bottomed at 171 on 11/20/08 and ran 134% trough-to-peak Historical Maximum Negativity for SOX relative to NDX is NDX/SOX -800 Source: Jefferies and Capital IQ page 3 of

4 SOX/SPX Values Indexed on 12/8/08 SOX/SPX Values Indexed on 09/08/04 25-Feb Aug Feb Apr Mar Sep Mar May Apr Oct Apr Jun May Nov May Jul Jun Dec Jun Aug Jul Jan Jul Sep Aug Feb Oct Aug Mar Sep Nov Sep Oct Apr Dec Oct May Nov Jan Nov Dec Jun Dec Feb-05 SOX/SPX Values Indexed on 7/17/12 SOX/SPX Values Indexed on 7/17/12 SOX/SPX Values Indexed on 09// SOX/SPX Values Indexed on 07/21/06 26-Feb Apr- 27-Feb-12 1-Feb Mar-12 1-Mar May- 27-Mar-12 1-Apr Apr Apr Jun- 1-May May May Jul- 1-Jun Jun Jun Aug- 1-Jul Jul Jul Sep- 1-Aug Aug Oct- 26-Aug-12 1-Sep Sep Nov- 26-Sep-12 1-Oct Oct Dec- 26-Oct-12 1-Nov Nov Jan Nov Dec-12 1-Dec Dec Feb-11 SOX/SPX Values Indexed on 7/17/12 SOX/SPX Values Indexed on 07/17/12 Chart 7: Relative SOX/SPX Values in 2004 and 2012 Chart 9: Relative SOX/SPX Values in 2006 and SOX bottomed at 352 on 09/08/04 and ran 57% trough-to-peak (4/04-2/05) SOX bottomed at 385 on 07/21/06 and ran 4 trough-to-peak (2/06-12/07) 1.3 (2/12 - /12) (2/12 - /12) Chart 8: Relative SOX/SPX Values in 2008 and 2012 Source: Capital IQ, Jefferies Chart : Relative SOX/SPX Values in 20 and SOX bottomed at 171 on 11/20/08 and ran 134% trough-to-peak SOX bottomed at on 08/31/ and ran 54% trough-to-peak 1.3 (2/12 - /12) (8/08-6/09) (2/12 - /12) (4/ - 2/11) page 4 of

5 EV/S vs. Avg EV/S at Cycle Troughs 45% % 33% 3 28% 26% 3% -4% -4% -5% -% % -3-58% -64% -75% EV/S, Current 2008 Trough 187% % 115% 8% 85% 76% 58% 36% 35% 2 13% - -7% -% -17% -53% Semis Discounting a Worse than Average Trough But Not an 08-Style Financial Crisis In the Chart directly below, we compare the EV/S today to the average EV/S during cycle troughs over the past half dozen years ( 06, 08, ). A stock with a negative reading indicates that the EV/S today is lower than the average of those previous cycles. Our interpretation of Chart below is that 5 of our coverage universe is discounting something worse that the average trough over the past decade. In the Chart directly below, we compare the EV/S today to the EV/S when semis troughed during the 2008 financial crisis. Here, only,,,, and are close to those valuation levels. Our take on these slides is that semis are discounting something worse than the average trough, but not as bad as the 2008 financial crisis. Chart 11: EV/Sales (trailing) Current vs. Avg at Past Decade Troughs 5 5 near or below the average EV/S at cycle troughs over the past half-dozen years('06, '08 and '). Chart 12: EV/Sales (trailing) Current vs. 08 Financial Crisis Trough near or below EV/S at the financial crisis('08) trough including,,, and Source: Capital IQ, Jefferies page 5 of

6 Chart 13: EV/S (trailing): Current and vs. Cycle Troughs over 06, 08 and Co P/E TTM P/E NTM P/TB Current EV/S Source: Jefferies, company data, CAPIQ EV/S at Stock Trough Avg Trough EV/S ('06, '08, % Diff Current vs Min % Diff Current EV/S vs. '08 Trough EV/S % Diff Current EV/S vs. Avg Trough EV/S ('06, '08, ') % 127% 45% % 58% % -53% -58% % 8% -5% % 85% 28% NA % -% % % -64% % 35% 3% % 187% -4% % 13% % -17% -75% % -7% -24% % % 115% -% % 36% % 5% % % 76% 34% Median % -4% Average % -% Min EV/S page 6 of

7 WTD Stock Performance YTD Stock Performance 8% ^sox ^spx 56% ^spx ^sox 6% 17% 13% 13% 9% 8% 7% 5% 5% 5% 3% 3% - -9% -1-13% -13% -13% -% -18% -2-27% -35% -36% -44% % -5% -5% -5% -6% Stock Performance QTD Stock Performance 16% ^spx ^sox 7 ^spx ^sox 9% 7% 4% 4% 3% 19% 18% % 13% 13% 5% 4% - -4% -5% -6% -6% -8% -8% -% -13% -13% -% -17% % -9% % -15% % -27% -3-35% -38% -38% -43% -3-33% -58% -6-75% -64% Chart : WTD Stock Performance % Chart 15: QTD Stock Performance 3 8% 2 6% % 4% - -4% -6% -8% -% Chart 16: YTD Stock Performance 8 Chart 17: Stock Performance page 7 of

8 P/Tangible BV P/E TTM EV/Sales TTM P/E NTM Chart 18: P/E TTM Chart 19: P/E NTM Chart 20: P/Tangible BV 12 Source: Capital IQ, Jefferies Chart 21: EV/Sales TTM page 8 of

9 EV/FCF FCF Yield (%) 13% 1 % 9% 9% 9% 36 8% 34 8% 16 8% 16 7% 16 7% 6% 6% 6% 12 6% 12 5% 12 4% Net Cash Per Share ($) Dividend Yield (%) 4.4% % % 2.4% 1.8% 1.3% 1.3% Chart 22: EV/FCF (2012) 40 Chart 23: Dividend Yield (%) 5% % % Chart 24: 2012 FCF Yield (%) 15% % Source: Capital IQ Jefferies Chart 25: Net Cash/Share $ $5 $0 $9.5 $7.9 $6.4 $5.2 $5.2 $4.4 $3.9 $3.8 $3.7 $2.9 $2.2 $2.1 $2.1 $1.6 $1.6 $0.8 $0.6 $0.6 $0.5 -$0.7-$0.7 -$-$1.8 5% -$5 -$ -$11.4 -$15 Source: Capital IQ Jefferies Source: Capital IQ Jefferies page 9 of

10 Chart 26: Semi Valuation Table Ticker Price Market JEF EPS Street EPS JEF Revenues Street Revenues P/E EV/S FCF Yield EV/FCF Rating PT 26-Oct-12 Cap 2012E 2013E 2012E 2013E 2012E 2013E 2012E 2013E 2012E 2013E 2012E 2013E 2012 Large Cap* $11,921 Hold $44.0 $4 $2.59 $2.22 $2.59 $2,1 $2,887 $2,751 $2, % 7% $9,836 Hold $36.0 $1.74 $1.82 $1.74 $1.92 $1,799 $1,969 $1,799 $2, % 16% $1,542 Buy $5.0 -$0.04 -$0.02 -$0.21 -$0.24 $5,409 $4,813 $5,422 $4, % $8,458 Buy $43.0 $2.79 $3.08 $2.82 $3.12 $1,665 $1,572 $2,408 $2, % 9% $18,389 Buy $40.0 $2.89 $2.93 $2.88 $2.96 $7,992 $8,861 $7,975 $8, % $113,8 Hold $24.0 $2.20 $2.17 $2.21 $2. $53,464 $54,647 $53,443 $54, % 9% $7,453 Hold $35.0 $1.79 $1.93 $1.75 $1.85 $1,288 $1,357 $1,288 $1, % 7% $6,463 Buy $38.0 $1.89 $2.27 $1.91 $2.17 $1,519 $1,809 $1,528 $1, % 8% 7.76 $4,423 Hold $9.0 $0.87 $2 $0.86 $0.88 $3,178 $3,356 $3,6 $3, % $581 Buy $2 $0. $0.18 $0.96 $6 $302 $322 $304 $ % 8% $8,297 Buy $33.0 $1.66 $1.99 $1.68 $1.92 $2,409 $2,593 $2,421 $2, % 8% $7,509 Hold $16.0 $5 $8 $3 $8 $4,415 $4,594 $4,368 $4, % % $6,079 Buy $28.0 $1.62 $2.44 $1.71 $2.58 $4,334 $4,602 $4,336 $4, % 13% $2,8 Buy $9.0 $0.57 $0.87 $0.55 $0.76 $2,979 $3,186 $2,979 $3, % 15% $32,998 Buy $33.0 $1.84 $2.05 $1.64 $1.74 $12,796 $13,3 $12,780 $12, % 8% $8,873 Hold $36.0 $1.79 $1.96 $1.79 $1.96 $2,213 $2,266 $2,213 $2, % 7% 12 Small-Mid Cap & Memory ** 3.97 $73 Buy $8.0 $0.32 $0.42 $0.45 $0.63 $4 $168 $3 $ $1,485 Buy $37.0 $0.34 $0 $0.35 $0.99 $233 $3 $234 $ $926 Hold $33.0 $0.77 $0.86 $0.78 $7 $51 $61 $51 $ $249 Buy $16.0 $0.24 $0.59 $0.23 $0.53 $96 $131 $96 $ % $443 Buy $5.0 -$0.01 $0.30 -$0.04 $0.24 $284 $308 $284 $ % 7% 5.47 $5,542 Buy $.0 -$1 $0.11 -$0.24 $0.55 $8,056 $9,4 $8,212 $9, % $1,098 Hold $6.5 $0.37 $0.50 $0.35 $0.48 $553 $602 $547 $ $,313 Buy $5 $2.02 $3.38 $2.02 $3.40 $5,011 $6,290 $5,042 $5, % Median % 8% 12 Average % 8% Total $122,331 $129,223 $123,770 $129,606 * Mark Lipacis ** Sundeep Bajikar Source: Jefferies, company data, Capital IQ page of

11 Analyst Certification I, Mark Lipacis, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report. I, Sundeep Bajikar, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report. I, Jonnathan Lee, certify that all of the views expressed in this research report accurately reflect my personal views about the subject security(ies) and subject company(ies). I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research report. As is the case with all Jefferies employees, the analyst(s) responsible for the coverage of the financial instruments discussed in this report receives compensation based in part on the overall performance of the firm, including investment banking income. We seek to update our research as appropriate, but various regulations may prevent us from doing so. Aside from certain industry reports published on a periodic basis, the large majority of reports are published at irregular intervals as appropriate in the analyst's judgement. For Important Disclosure information on companies recommended in this report, please visit our website at Disclosures.action or call Meanings of Jefferies Ratings Buy - Describes stocks that we expect to provide a total return (price appreciation plus yield) of 15% or more within a 12-month period. Hold - Describes stocks that we expect to provide a total return (price appreciation plus yield) of plus 15% or minus % within a 12-month period. Underperform - Describes stocks that we expect to provide a total negative return (price appreciation plus yield) of % or more within a 12-month period. The expected total return (price appreciation plus yield) for Buy rated stocks with an average stock price consistently below $ is 2 or more within a 12-month period as these companies are typically more volatile than the overall stock market. For Hold rated stocks with an average stock price consistently below $, the expected total return (price appreciation plus yield) is plus or minus 2 within a 12-month period. For Underperform rated stocks with an average stock price consistently below $, the expected total return (price appreciation plus yield) is minus 2 within a 12- month period. NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/ or Jefferies policies. CS - Coverage Suspended. Jefferies has suspended coverage of this company. NC - Not covered. Jefferies does not cover this company. Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securities regulations prohibit certain types of communications, including investment recommendations. Monitor - Describes stocks whose company fundamentals and financials are being monitored, and for which no financial projections or opinions on the investment merits of the company are provided. Valuation Methodology Jefferies' methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected total return over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of market risk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/CF, P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns, and return on equity (ROE) over the next 12 months. Conviction List Methodology 1. The aim of the conviction list is to publicise the best individual stock ideas from Jefferies Global Research 2. Only stocks with a Buy rating are allowed to be included in the recommended list. 3. Stocks are screened for minimum market capitalisation and adequate daily turnover. Furthermore, a valuation, correlation and style screen is used to ensure a well-diversified portfolio. 4. Stocks are sorted to a maximum of 30 stocks with the maximum country exposure at around 5. Limits are also imposed on a sector basis. 5. Once a month, analysts are invited to recommend their best ideas. Analysts stock selection can be based on one or more of the following: non-consensus investment view, difference in earnings relative to Consensus, valuation methodology, target upside/downside % relative to the current stock price. These are then assessed against existing holdings to ensure consistency. Stocks that have either reached their target price, been downgraded over the course of the month or where a more suitable candidate has been found are removed. 6. All stocks are inserted at the last closing price and removed at the last closing price. There are no changes to the conviction list during the month. 7. Performance is calculated in US dollars on an equally weighted basis and is compared to MSCI World AC US$. 8. The conviction list is published once a month whilst global equity markets are closed. 9. Transaction fees are not included.. All corporate actions are taken into account. page 11 of

12 Risk which may impede the achievement of our Price Target This report was prepared for general circulation and does not provide investment recommendations specific to individual investors. As such, the financial instruments discussed in this report may not be suitable for all investors and investors must make their own investment decisions based upon their specific investment objectives and financial situation utilizing their own financial advisors as they deem necessary. Past performance of the financial instruments recommended in this report should not be taken as an indication or guarantee of future results. The price, value of, and income from, any of the financial instruments mentioned in this report can rise as well as fall and may be affected by changes in economic, financial and political factors. If a financial instrument is denominated in a currency other than the investor's home currency, a change in exchange rates may adversely affect the price of, value of, or income derived from the financial instrument described in this report. In addition, investors in securities such as ADRs, whose values are affected by the currency of the underlying security, effectively assume currency risk. Other Companies Mentioned in This Report Advanced Micro Devices, Inc. (: $2.07, BUY) Altera Corp (: $30.40, HOLD) Audika ( FP: 9.25, BUY) Avago Technologies (: $33.83, BUY) BCD Semiconductor Manufacturing Ltd. (: $3.98, BUY) Broadcom Corporation (: $31.76, BUY) Cavium Inc. (: $29.90, BUY) EZchip Semiconductor Ltd. (: $32.12, HOLD) Inphi Corporation (: $8.78, BUY) Intel Corporation (: $21.95, HOLD) Lattice Semiconductor Corporation (: $3.79, BUY) Linear (: $31.58, HOLD) M/A-COM Solutions Holdings, Inc. (: $12.30, BUY) Marvell Group Ltd. (: $7.76, HOLD) Maxim Integrated Products, Inc. (: $27.77, BUY) Microchip Inc. (: $31.73, BUY) Micron, Inc. (: $5.47, BUY) NVIDIA Corporation (: $12.05, HOLD) NXP NV (: $24.02, BUY) ON Semiconductor Corporation (: $6.15, BUY) PMC-Sierra, Inc. (: $4.89, HOLD) SanDisk Corporation (: $42.23, BUY) Texas Instruments Incorporated (: $28.92, BUY) Xilinx Corp (: $32.83, HOLD) Distribution of Ratings IB Serv./Past 12 Mos. Rating Count Percent Count Percent BUY % % HOLD % % UNDERPERFORM % Other Important Disclosures Jefferies Equity Research refers to research reports produced by analysts employed by one of the following Jefferies Group, Inc. ( Jefferies ) group companies: United States: Jefferies & Company, Inc., which is an SEC registered firm and a member of FINRA. United Kingdom: Jefferies International Limited, which is authorized and regulated by the Financial Services Authority; registered in England and Wales No ; registered office: Vintners Place, 68 Upper Thames Street, London EC4V 3BJ; telephone +44 (0) ; facsimile +44 (0) Hong Kong: Jefferies Hong Kong Limited, which is licensed by the Securities and Futures Commission of Hong Kong with CE number ATS546; located at Suite 2201, 22nd Floor, Cheung Kong Center, 2 Queen s Road Central, Hong Kong. Singapore: Jefferies Singapore Limited, which is licensed by the Monetary Authority of Singapore; located at 80 Raffles Place #15-20, UOB Plaza 2, Singapore , telephone: Japan: Jefferies (Japan) Limited, Tokyo Branch, which is a securities company registered by the Financial Services Agency of Japan and is a member of the Japan Securities Dealers Association; located at Hibiya Marine Bldg, 3F, Yuraku-cho, Chiyoda-ku, Tokyo ; telephone ; facsimile page 12 of

13 India: Jefferies India Private Limited, which is licensed by the Securities and Exchange Board of India as a Merchant Banker (I ) and a Stock Broker with Bombay Stock Exchange Limited (INB ) and National Stock Exchange of India Limited (INB ) in the Capital Market Segment; located at 42/43, 2 North Avenue, Maker Maxity, Bandra-Kurla Complex, Bandra (East) Mumbai , India; Tel This material has been prepared by Jefferies employing appropriate expertise, and in the belief that it is fair and not misleading. The information set forth herein was obtained from sources believed to be reliable, but has not been independently verified by Jefferies. Therefore, except for any obligation under applicable rules we do not guarantee its accuracy. Additional and supporting information is available upon request. Unless prohibited by the provisions of Regulation S of the U.S. Securities Act of 1933, this material is distributed in the United States ("US"), by Jefferies & Company, Inc., a US-registered broker-dealer, which accepts responsibility for its contents in accordance with the provisions of Rule 15a-6, under the US Securities Exchange Act of Transactions by or on behalf of any US person may only be effected through Jefferies & Company, Inc. In the United Kingdom and European Economic Area this report is issued and/or approved for distribution by Jefferies International Limited and is intended for use only by persons who have, or have been assessed as having, suitable professional experience and expertise, or by persons to whom it can be otherwise lawfully distributed. Jefferies International Limited has adopted a conflicts management policy in connection with the preparation and publication of research, the details of which are available upon request in writing to the Compliance Officer. Jefferies International Limited may allow its analysts to undertake private consultancy work. Jefferies International Limited s conflicts management policy sets out the arrangements Jefferies International Limited employs to manage any potential conflicts of interest that may arise as a result of such consultancy work. For Canadian investors, this material is intended for use only by professional or institutional investors. None of the investments or investment services mentioned or described herein is available to other persons or to anyone in Canada who is not a "Designated Institution" as defined by the Securities Act (Ontario). For investors in the Republic of Singapore, this material is provided by Jefferies Singapore Limited pursuant to Regulation 32C of the Financial Advisers Regulations. The material contained in this document is intended solely for accredited, expert or institutional investors, as defined under the Securities and Futures Act (Cap. 289 of Singapore). If there are any matters arising from, or in connection with this material, please contact Jefferies Singapore Limited. In Japan this material is issued and distributed by Jefferies (Japan) Limited to institutional investors only. In Hong Kong, this report is issued and approved by Jefferies Hong Kong Limited and is intended for use only by professional investors as defined in the Hong Kong Securities and Futures Ordinance and its subsidiary legislation. In the Republic of China (Taiwan), this report should not be distributed. In India this report is made available by Jefferies India Private Limited. In Australia this information is issued solely by Jefferies International Limited and is directed solely at wholesale clients within the meaning of the Corporations Act 2001 of Australia (the "Act") in connection with their consideration of any investment or investment service that is the subject of this document. Any offer or issue that is the subject of this document does not require, and this document is not, a disclosure document or product disclosure statement within the meaning of the Act. Jefferies International Limited is authorised and regulated by the Financial Services Authority under the laws of the United Kingdom, which differ from Australian laws. Jefferies International Limited has obtained relief under Australian Securities and Investments Commission Class Order 03/99, which conditionally exempts it from holding an Australian financial services licence under the Act in respect of the provision of certain financial services to wholesale clients. Recipients of this document in any other jurisdictions should inform themselves about and observe any applicable legal requirements in relation to the receipt of this document. This report is not an offer or solicitation of an offer to buy or sell any security or derivative instrument, or to make any investment. Any opinion or estimate constitutes the preparer's best judgment as of the date of preparation, and is subject to change without notice. Jefferies assumes no obligation to maintain or update this report based on subsequent information and events. Jefferies, its associates or affiliates, and its respective officers, directors, and employees may have long or short positions in, or may buy or sell any of the securities, derivative instruments or other investments mentioned or described herein, either as agent or as principal for their own account. Upon request Jefferies may provide specialized research products or services to certain customers focusing on the prospects for individual covered stocks as compared to other covered stocks over varying time horizons or under differing market conditions. While the views expressed in these situations may not always be directionally consistent with the long-term views expressed in the analyst's published research, the analyst has a reasonable basis and any inconsistencies can be reasonably explained. This material does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation in this report is suitable for their particular circumstances and, if appropriate, seek professional advice, including tax advice. The price and value of the investments referred to herein and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments. This report has been prepared independently of any issuer of securities mentioned herein and not in connection with any proposed offering of securities or as agent of any issuer of securities. None of Jefferies, any of its affiliates or its research analysts has any authority whatsoever to make any representations or warranty on behalf of the issuer(s). Jefferies policy prohibits research personnel from disclosing a recommendation, investment rating, or investment thesis for review by an issuer prior to the publication of a research report containing such rating, recommendation or investment thesis. Any comments or statements made herein are those of the author(s) and may differ from the views of Jefferies. This report may contain information obtained from third parties, including ratings from credit ratings agencies such as Standard & Poor s. Reproduction and distribution of third party content in any form is prohibited except with the prior written permission of the related third party. Third party content providers do not guarantee the accuracy, completeness, timeliness or availability of any information, including ratings, and are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such content. Third party content providers give no express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose or use. Third party content providers shall not be liable for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use of their content, including ratings. Credit ratings are statements of opinions and are not statements of fact or recommendations to purchase, hold or sell securities. They do not address the suitability of securities or the suitability of securities for investment purposes, and should not be relied on as investment advice. Jefferies research reports are disseminated and available primarily electronically, and, in some cases, in printed form. Electronic research is simultaneously available to all clients. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Jefferies. Neither Jefferies nor any officer nor employee of Jefferies accepts any liability whatsoever for any direct, indirect or consequential damages or losses arising from any use of this report or its contents. For Important Disclosure information, please visit our website at or call JEFFERIES page 13 of

14 2012 Jefferies Group, Inc. page of

Micron Tech. (MU) EQUITY RESEARCH AMERICAS. Moore Stress: Expect DRAM Prices to Continue to Increase. BUY Price target $10.00 Price $9.

Micron Tech. (MU) EQUITY RESEARCH AMERICAS. Moore Stress: Expect DRAM Prices to Continue to Increase. BUY Price target $10.00 Price $9. USA Technology Semiconductors Micron Tech. (MU) Moore Stress: Expect DRAM Prices to Continue to Increase Key Takeaway DRAM spot prices have spiked up 106% and contract prices increased by 30% from their

More information

Precision Equipment Obstacles for EUVL

Precision Equipment Obstacles for EUVL INDUSTRY NOTE Japan Industrials Obstacles for EUVL Key Takeaway It seems that developing the mirror is one of the major obstacles in realizing EUVL lithography. We also summarize the other obstacles (both

More information

Lattice Semiconductor (LSCC) Moore Stress Beneficiary - Takeaways From Management Meetings

Lattice Semiconductor (LSCC) Moore Stress Beneficiary - Takeaways From Management Meetings USA Technology Semiconductors Lattice Semiconductor (LSCC) Moore Stress Beneficiary - Takeaways From Management Meetings Key Takeaway After hosting investor meetings with CFO Joe Bedewi and VP Ops. Doug

More information

Health Care Facilities

Health Care Facilities Page 1 of 5 INDUSTRY NOTE USA Healthcare Health Care Facilities July 21, 2014 Health Care Facilities Hospital Survey: Inpatient Volumes Were Positive; Expect More Doc Outsourcing Key Takeaway We conducted

More information

Major Bulk Commodities: Trends and Outlook

Major Bulk Commodities: Trends and Outlook Major Bulk Commodities: Trends and Outlook June 19, 2013 Christopher LaFemina European Metals and Mining Equity Research US: 212 336 7304 UK: +44 (0)207 029 8131 clafemina@jefferies.com Jefferies LLC Seaborne

More information

Biotechnology BIIB/Bioverativ: Filings Reveal Incremental New Info On Hemophilia Spinoff

Biotechnology BIIB/Bioverativ: Filings Reveal Incremental New Info On Hemophilia Spinoff INDUSTRY NOTE USA Healthcare BIIB/Bioverativ: Filings Reveal Incremental New Info On Hemophilia Spinoff Key Takeaway This afternoon the Form 10 for BIIB s proposed hemophilia spinoff Bioverativ was issued,

More information

FY3/17 JEF forecast. FY3/17 company forecast. Implied progression

FY3/17 JEF forecast. FY3/17 company forecast. Implied progression INDUSTRY NOTE Japan Financials Financials Today at the Races Key Takeaway Today's runners: Nikkei previewed Q1 FY3/17 banks earnings; Janus reported 2Q16 results slight operating miss with positive flows;

More information

Fufeng Group Limited (546 HK) Second Price Increase in Two Months

Fufeng Group Limited (546 HK) Second Price Increase in Two Months COMPANY NOTE China Industrials Chemicals Fufeng Group Limited (546 HK) Second Price Increase in Two Months Key Takeaway Fufeng has adjusted its MSG prices again, the second time since late April. Excluding

More information

Computer Services & IT Consulting JPM Card Volume Growth Accelerates

Computer Services & IT Consulting JPM Card Volume Growth Accelerates INDUSTRY NOTE USA Technology JPM Card Volume Growth Accelerates Key Takeaway Earlier, JPM (largest V/MA credit card issuer) reported 2Q16 results. US credit card volume growth accelerated 30 bps to 8.2%

More information

Public Service Ent. (PEG) Another Bad Bonus

Public Service Ent. (PEG) Another Bad Bonus COMPANY NOTE USA Energy Electric Utilities Public Service Ent. (PEG) Another Bad Bonus Key Takeaway PEG hosted its investor conference and affirmed 2016 ongoing EPS guidance of $2.80-$3.00 and as a result

More information

American Tower (AMT) EQUITY RESEARCH AMERICAS. Strong Execution Continues. BUY Price target $ Price $90.01 COMPANY NOTE.

American Tower (AMT) EQUITY RESEARCH AMERICAS. Strong Execution Continues. BUY Price target $ Price $90.01 COMPANY NOTE. COMPANY NOTE USA Telecommunications Telecom Services American Tower (AMT) Strong Execution Continues Key Takeaway AMT beat on all key financial metrics, with acquisitions and strong organic growth expected

More information

Tullett Prebon (LSE: TLPR LN)

Tullett Prebon (LSE: TLPR LN) December 1, 2008 Financial Services Market Structure & Trading United Kingdom Company Update Rating: Price: Price Target: Bloomberg: BUY 150p 260p LSE: TLPR LN Market Data 52-Week Range: 540p-125p Total

More information

Kinross Gold Corp. (KGC)

Kinross Gold Corp. (KGC) COMPANY NOTE USA Natural Resources Metals & Mining Kinross Gold Corp. (KGC) Good Operational Performance, Capex Lowered Key Takeaway Kinross reported adjusted 3Q EPS of $0.10, ahead of our and street s

More information

Verizon Communications (VZ) ARPA Headwinds Likely to Persist

Verizon Communications (VZ) ARPA Headwinds Likely to Persist COMPANY NOTE USA Telecommunications Telecom Services Verizon Communications (VZ) ARPA Headwinds Likely to Persist Key Takeaway Similar to 3Q, better profitability in both Wireless and Wireline drove a

More information

BCD Semiconductor (BCDS)

BCD Semiconductor (BCDS) COMPANY NOTE USA Technology Semiconductors BCD Semiconductor (BCDS) Moore Stress Beneficiary Taking Share - Buy Key Takeaway Q3 EPS beat highlights another quarter of consistent execution and share gains

More information

SanDisk Corporation (SNDK) Moore Stress in Play - Expect Gross Margin Upside, Raise PT to $59

SanDisk Corporation (SNDK) Moore Stress in Play - Expect Gross Margin Upside, Raise PT to $59 COMPANY NOTE USA Technology Semiconductors SanDisk Corporation () Moore Stress in Play - Expect Gross Margin Upside, Raise PT to $59 Key Takeaway We continue to believe Moore Stress is driving industry

More information

American Electric Power (AEP)

American Electric Power (AEP) COMPANY NOTE USA Energy Electric Utilities American Electric Power (AEP) Strong 3Q15 and Increased 2015 Guidance Key Takeaway AEP reported 3Q15 EPS of $1.06, which beat Street expectations of $1.00 and

More information

Consumer. Nevada Numbers - Average Nevada Income Statements Back To 1991

Consumer. Nevada Numbers - Average Nevada Income Statements Back To 1991 January 30, 2009 Consumer Casinos & Gaming Consumer Nevada Numbers - Average Nevada Income Statements Back To 1991 Investment Summary The enclosed note gives readers a financial snapshot of the typical

More information

HEG (HEG IN) EQUITY RESEARCH INDIA. Strong Quarter; Raising PT. BUY Price target INR5, (from INR4,400.00) Price INR4,343.

HEG (HEG IN) EQUITY RESEARCH INDIA. Strong Quarter; Raising PT. BUY Price target INR5, (from INR4,400.00) Price INR4,343. COMPANY NOTE India Natural Resources Materials (Steel) HEG (HEG IN) Strong Quarter; Raising PT Key Takeaway HEG reported strong quarter driven by higher realisation of US$14,333/t (vs US $12,500/t JEFe).

More information

TCL Communication (2618 HK)

TCL Communication (2618 HK) COMPANY NOTE HKG Technology Comm. Equipment TCL Communication (2618 HK) Look Forward to Smartphone Growth Key Takeaway TCL Comm reported Q1 earnings materially below our/consensus expectations due to pricing

More information

Stryker Corp. (SYK) EQUITY RESEARCH AMERICAS. Recon Strong in 4Q; Stability Expected for HOLD Price target $ Price $96.

Stryker Corp. (SYK) EQUITY RESEARCH AMERICAS. Recon Strong in 4Q; Stability Expected for HOLD Price target $ Price $96. COMPANY NOTE USA Healthcare Medical Supplies & Devices Stryker Corp. (SYK) Recon Strong in 4Q; Stability Expected for 2016 Key Takeaway SYK 4Q results showed a surge in recon where a good domestic volumes,

More information

Technology EQUITY RESEARCH GLOBAL. PC Hardware: More Headwinds Ahead INDUSTRY NOTE. Hong Kong Technology 11 April 2013

Technology EQUITY RESEARCH GLOBAL. PC Hardware: More Headwinds Ahead INDUSTRY NOTE. Hong Kong Technology 11 April 2013 INDUSTRY NOTE Hong Kong PC Hardware: More Headwinds Ahead Key Takeaway PC market continues to deteriorate with unlikely recovery in C2Q13 before Intel launching Haswell. For Asian PC vendors, we see additional

More information

Metals & Mining Incremental Positives for Iron Ore

Metals & Mining Incremental Positives for Iron Ore INDUSTRY NOTE Global Natural Resources Incremental Positives for Iron Ore Key Takeaway A likely shift in Chinese real estate policy to address under-supply of affordable housing in major cities should

More information

Semiconductors 3Q14 Looks Like a Classic Mid-Cycle Correction - More Bullish on Semis

Semiconductors 3Q14 Looks Like a Classic Mid-Cycle Correction - More Bullish on Semis INDUSTRY NOTE USA 3Q14 Looks Like a Classic Mid-Cycle Correction - More Bullish on Semis Key Takeaway The recent trading in the SOX post MCHP's downward revision appears to follow the pattern of a classic

More information

Galapagos (GLPG NA) EQUITY RESEARCH EUROPE. Cash Burn Aim Unchanged at 1Q; Pipeline On-track; Call to Focus on CF Specifics

Galapagos (GLPG NA) EQUITY RESEARCH EUROPE. Cash Burn Aim Unchanged at 1Q; Pipeline On-track; Call to Focus on CF Specifics Netherlands Healthcare Biotechnology Galapagos (GLPG NA) Cash Burn Aim Unchanged at 1Q; Pipeline On-track; Call to Focus on CF Specifics Key Takeaway 1Q cash burn is as expected and 2018 outlook reiterated

More information

AveXis (AVXS) EQUITY RESEARCH AMERICAS. Survey Says...Parents Would Be Interested In AVXS-101 Pivotal Trial. BUY Price target $50.00 Price $41.

AveXis (AVXS) EQUITY RESEARCH AMERICAS. Survey Says...Parents Would Be Interested In AVXS-101 Pivotal Trial. BUY Price target $50.00 Price $41. COMPANY NOTE USA Healthcare Biotechnology AveXis (AVXS) Survey Says...Parents Would Be Interested In AVXS-101 Pivotal Trial Key Takeaway Since there are investor questions surrounding AVXS' ability to

More information

Materials (Steel) China s Silicon Price Inflects; Western US/EU Continue Gains

Materials (Steel) China s Silicon Price Inflects; Western US/EU Continue Gains INDUSTRY NOTE USA Industrials China s Silicon Price Inflects; Western US/EU Continue Gains Key Takeaway China s Si metal prices appear to have stabilized and inflected over the past week, an encouraging

More information

Strides Arcolab (STR IN)

Strides Arcolab (STR IN) COMPANY NOTE India Healthcare Pharmaceuticals Strides Arcolab () 1Q18: Weak quarter; Expect recovery ahead Key Takeaway STR reported weak 1Q18 as approval delays, mix and operating leverage drove 700bps

More information

FLASH Mega Manunggal Company Update 2 April 2018

FLASH Mega Manunggal Company Update 2 April 2018 FLASH Mega Manunggal FLASH Mega Manunggal Mandiri Sekuritas Analyst Audrey Hanzdima +6221 5296 9434 audrey.hanzdima@mandirisek.co.id Adrian Joezer +6221 5296 9415 adrian.joezer@mandirisek.co.id Sector:

More information

Materials (Steel) Scrap Preview: May Momentum Persists on Strong Exports; Up +$25-30/t

Materials (Steel) Scrap Preview: May Momentum Persists on Strong Exports; Up +$25-30/t INDUSTRY NOTE USA Industrials Scrap Preview: May Momentum Persists on Strong Exports; Up +$25-30/t Key Takeaway Recyclers expect May scrap prices to move up +$25-30/t on a) strong export demand/pricing

More information

Yamaha Motor (7272 JP)

Yamaha Motor (7272 JP) COMPANY NOTE JPN Industrials Autos & Auto Parts Yamaha Motor (7272 JP) Initiate at Hold: Concern over Declining Competitiveness in Emerging Countries Key Takeaway Investment sentiment for Yamaha would

More information

Dry Bulk Sector Panel

Dry Bulk Sector Panel Capital Link Forum March 12, 2018 Maritime Shipping Dry Bulk Sector Panel Randy Giveans Maritime Shipping Group Head Equity Analyst rgiveans@jefferies.com 713.651.3829 Jefferies LLC Disclaimer: Important

More information

Trumponomics, The Honma Accord & JGB Bondfire

Trumponomics, The Honma Accord & JGB Bondfire May 2017 Trumponomics, The Honma Accord & JGB Bondfire David Zervos Chief Market Strategist dzervos@jefferies.com +1 212 323 7586 The Trump policy equation Summarizing The Trump Policy Effect On Expected

More information

Semi. Cap. Equipment Foundry Competition - Samsung 14nm vs. TSMC 16nm is Just the Beginning

Semi. Cap. Equipment Foundry Competition - Samsung 14nm vs. TSMC 16nm is Just the Beginning INDUSTRY NOTE USA Technology Foundry Competition - Samsung 14nm vs. TSMC 16nm is Just the Beginning Key Takeaway Starting in 2H14 we continue to expect Samsung's 14nm to disrupt TSMC's 16/16+ by taking

More information

Research in Motion (RIMM)

Research in Motion (RIMM) COMPANY NOTE USA Technology Telecom Equipment/Wireless Research in Motion (RIMM) Limited Patent Value; Cut Target to Salvage Value of $21 as We Wait for QNX Key Takeaway In consultation with industry experts,

More information

America's Car-Mart (CRMT)

America's Car-Mart (CRMT) COMPANY NOTE Target Estimate Change USA Financials Consumer Finance February 20, 2014 America's Car-Mart (CRMT) CRMT 3Q14: Competitive Intensity Leads to Higher Credit Costs Key Takeaway CRMT missed consensus

More information

E-FIT trial results indicate no clinical improvement

E-FIT trial results indicate no clinical improvement NEXSTIM OYJ Medical Technology 3 September 2018 11:44 BST FLASH NOTE Nexstim OYJ (NXTMH-FI) E-FIT trial results indicate no clinical improvement OUTPERFORM Price target 1.23 Price 0.23 KEY TAKEAWAY Today,

More information

VIX to Fall; Stocks to Rise; Small to Outperform

VIX to Fall; Stocks to Rise; Small to Outperform RBC Capital Markets, LLC October 14, 2014 VIX to Fall; Stocks to Rise; Small to Outperform Market Delivers Above-Average Returns Following Volatility Spikes Investor concerns regarding global growth have

More information

Ferroglobe (GSM) EQUITY RESEARCH AMERICAS

Ferroglobe (GSM) EQUITY RESEARCH AMERICAS COMPANY NOTE USA Industrials Materials (Steel) Ferroglobe (GSM) US Levies 4-135% Preliminary Si Metal Antidumping Duties; Reiterate Buy Key Takeaway The imposition of US Si metal import duties of 4-135%

More information

3Q 30 SEPTEMBER 2018 MFS EUROPEAN EQUITY EX U.K. (USD)

3Q 30 SEPTEMBER 2018 MFS EUROPEAN EQUITY EX U.K. (USD) 3Q 30 SEPTEMBER 2018 MFS EUROPEAN EQUITY EX U.K. (USD) INVESTMENT OVERVIEW TEAM Name (Years of industry experience) Title Matthew Barrett, ASIP (22 yrs.) Portfolio Manager Gabrielle Gourgey (23 yrs.) Institutional

More information

Manulife Financial Corp.

Manulife Financial Corp. I N S T I T U T I O N A L E Q U I T Y R E S E A R C H Robert Sedran, CFA 1 (416) 594-7874 Robert.Sedran@cibc.com Koki Akala, CFA 1 (416) 956-3723 Koki.Akala@cibc.com Maurissa Bell, CPA, CA 1 (416) 594-7283

More information

2Q 30 JUNE 2018 MFS GLOBAL EQUITY (AUD)

2Q 30 JUNE 2018 MFS GLOBAL EQUITY (AUD) 2Q 30 JUNE 2018 MFS GLOBAL EQUITY (AUD) INVESTMENT OVERVIEW TEAM Name (Years of industry experience) Title Roger Morley (21 yrs.) Portfolio Manager Ryan P. McAllister, CFA (15 yrs.) Portfolio Manager Ben

More information

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY? Company Update Simmtech (222800) Focus on 2H earnings Simmtech yesterday reported disappointing 4Q results, which compels us to cut our 2018 operating profit forecast by 10% to KRW52.9b and 12-month target

More information

All you need to know about the Golden Cross

All you need to know about the Golden Cross All you need to know about the Golden Cross Golden Cross means market base-building to higher returns A Golden Cross is when the 50-day moving average crosses above the 200-day moving average on the S&P

More information

Asia Equity Strategy Research Analysts Sakthi Siva

Asia Equity Strategy Research Analysts Sakthi Siva Asia Pacific Equity Research Investment Strategy Asia Equity Strategy Research Analysts Sakthi Siva 65 6212 3027 sakthi.siva@credit-suisse.com Kin Nang Chik 852 2101 7482 kinnang.chik@credit-suisse.com

More information

2Q 30 JUNE 2018 MFS EUROPEAN VALUE EQUITY (USD)

2Q 30 JUNE 2018 MFS EUROPEAN VALUE EQUITY (USD) 2Q 30 JUNE 2018 MFS EUROPEAN VALUE EQUITY (USD) INVESTMENT OVERVIEW TEAM Name (Years of industry experience) Title Benjamin Stone (22 yrs.) Portfolio Manager Pablo de la Mata (14 yrs.) Portfolio Manager

More information

Sizing Up the Online Lending Market: Key Trends & Themes

Sizing Up the Online Lending Market: Key Trends & Themes Sizing Up the Online Lending Market: Key Trends & Themes John Hecht jhecht@jefferies.com 415.229.1569 AGENDA Landscape of Specialty Finance Marketplace / Technology Enabled Lending Market Size, Trends

More information

Earnings sustainability and asset quality remain under pressure

Earnings sustainability and asset quality remain under pressure Bank of Chongqing (1963 HK; TP H KD6.85; H OLD) Bank of Chongqing (1963 HK) Equity Research Earnings sustainability and asset quality remain under pressure Huatai Research 30 October 2017 Equity China

More information

Demand for sovereign bonds: The importance of diversity

Demand for sovereign bonds: The importance of diversity Demand for sovereign bonds: The importance of diversity ECB Bond Market Contact Group 1 July 2014 Christoph Rieger, Head of Interest Rate and Credit Research, +49 69 136 87664 Key themes (1) Core: Investor

More information

KWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12.

KWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12. Equity Research Seeking balance between scale and profitability Downgrade to HOLD and revise down TP to HK$12.50: 2017 result missed our estimation; core net profit dropped by 19% YoY, expansion execution

More information

RMBS ARREARS STATISTICS

RMBS ARREARS STATISTICS RMBS ARREARS STATISTICS Australia (Excluding Non-Capital Market Issuance) At February 9, RMBS Performance Watch Australia at February 9, Australia Prime Standard & Poor's Rating Services Mortgage Performance

More information

NXP Semiconductors N.V. The UBS Valuation Report

NXP Semiconductors N.V. The UBS Valuation Report NXP Semiconductors N.V. The UBS Valuation Report 8 December 2017 DISCLAIMER This Valuation Report does not address the relative merits of any transaction involving any of the companies discussed herein

More information

ANZ-ROY MORGAN AUSTRALIAN CONSUMER CONFIDENCE MEDIA RELEASE. Figure 1. ANZ-Roy Morgan Australian Consumer Confidence and inflation expectations

ANZ-ROY MORGAN AUSTRALIAN CONSUMER CONFIDENCE MEDIA RELEASE. Figure 1. ANZ-Roy Morgan Australian Consumer Confidence and inflation expectations ANZ RESEARCH ANZ-ROY MORGAN AUSTRALIAN CONSUMER CONFIDENCE MEDIA RELEASE 17 APRIL 2018 CONTACT research@anz.com CONTRIBUTORS Mustafa Arif Junior Economist +91 80 6795 3801 mustafa.arif@anz.com David Plank

More information

Global Property & REIT Quantitative Analysis

Global Property & REIT Quantitative Analysis Global Property & REIT Quantitative Analysis 4th Quarter 2012 2n S&P Dow Jones Indices Quantitative Analysis Global Property & REIT Page 1 Contents S&P Global Property & REIT 3 S&P Developed Property &

More information

Figure 1. ANZ Heavy Traffic Index and GDP. Heavy traffic index, 3-month avg (LHS) Figure 2. ANZ Light Traffic Index and GDP

Figure 1. ANZ Heavy Traffic Index and GDP. Heavy traffic index, 3-month avg (LHS) Figure 2. ANZ Light Traffic Index and GDP ANZ Research ANZ NZ Truckometer 1 March 19 This is not personal advice. It does not consider your objectives or circumstances. Please refer to the Important Notice. CONTACT: Sharon Zollner Chief Economist

More information

Vertex (VRTX) EQUITY RESEARCH AMERICAS

Vertex (VRTX) EQUITY RESEARCH AMERICAS COMPANY NOTE USA Healthcare Biotechnology Vertex (VRTX) 3Q16: Next-Gens Good Enough To Proceed, A Meaningful Step Key Takeaway Numbers in line, but 3Q highlighted by both next-gen correctors, despite imperfect

More information

Software IBM 2Q15: Difficult Software Read Across Due to Secular Challenges

Software IBM 2Q15: Difficult Software Read Across Due to Secular Challenges INDUSTRY NOTE USA Technology IBM 2Q15: Difficult Read Across Due to Secular Challenges Key Takeaway As the third largest vendor in the world, we consider IBM s results a gauge on the industry, though we

More information

Important Notices Disclaimer: This document has been prepared by National Australia Bank Limited ABN 12 004 044 937 AFSL 230686 ( NAB ). Any advice contained in this document has been prepared without

More information

3Q 30 SEPTEMBER 2018 MFS U.K. EQUITY (USD)

3Q 30 SEPTEMBER 2018 MFS U.K. EQUITY (USD) 3Q 30 SEPTEMBER MFS U.K. EQUITY (USD) INVESTMENT OVERVIEW TEAM Name (Years of industry experience) Title Christopher Jennings, CFA (20 yrs.) Portfolio Manager David Shindler (17 yrs.) Portfolio Manager

More information

2Q 30 JUNE 2018 MFS INTERNATIONAL SMALL-MID CAP EQUITY (USD)*

2Q 30 JUNE 2018 MFS INTERNATIONAL SMALL-MID CAP EQUITY (USD)* 2Q 30 JUNE 2018 MFS INTERNATIONAL SMALL-MID CAP EQUITY (USD)* INVESTMENT OVERVIEW TEAM Name (Years of industry experience) Title David Antonelli (30 yrs.) Portfolio Manager Peter Fruzzetti (24 yrs.) Portfolio

More information

26.0x 19.8x 17.5x 16.5x

26.0x 19.8x 17.5x 16.5x COMPANY NOTE USA Technology Software Citrix (CTXS) Synergy User Conference and Analyst Day Key Takeaway We attended CTXS' annual user conference, Synergy, and Analyst Day in Las Vegas. Although there was

More information

MIXED MESSAGES. KEY POINTS The ANZ Truckometer indexes lifted in August.

MIXED MESSAGES. KEY POINTS The ANZ Truckometer indexes lifted in August. ANZ RESEARCH 11 September 18 CONTACT: Sharon Zollner Chief Economist Telephone: +6 9 357 9 Email: Sharon.Zollner@anz.com The next issue of the ANZ Truckometer is scheduled for release on 9 October 18 at

More information

US Equity Strategy EQUITY STRATEGY AMERICAS. JEF's SMID-Cap Themes: 8 is enough, go with the Momentum and 7 other themes STRATEGY NOTE

US Equity Strategy EQUITY STRATEGY AMERICAS. JEF's SMID-Cap Themes: 8 is enough, go with the Momentum and 7 other themes STRATEGY NOTE STRATEGY NOTE A Equity Strategy Equity Strategy JEF's SMID-Cap Themes: 8 is enough, go with the Momentum and 7 other themes Key Takeaway We thought 7 themes were enough but decided to add an 8th and that

More information

Semiconductors Moore Feedback - EUV Push?

Semiconductors Moore Feedback - EUV Push? INDUSTRY NOTE USA Technology Moore Feedback - EUV Push? Key Takeaway Our Japan and Europe colleagues have highlighted risk to EUV tool timelines which increases concerns around transistor costs we highlighted

More information

Shenhua Reuters: 1088.HK, Bloomberg: 1088 HK; YCM Reuters: 1171.HK, Bloomberg: 1171 HK

Shenhua Reuters: 1088.HK, Bloomberg: 1088 HK; YCM Reuters: 1171.HK, Bloomberg: 1171 HK 20 December 20 China Coal Market Decelerating production growth Firm spot coal prices expected in 2006: China s coal production in November only grew by 3.1% Y/Y, highlighting the production disruption

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

Multi Asset Indices Selection and Rebalance Dates

Multi Asset Indices Selection and Rebalance Dates 29 January 2015 DBIQ Index Selection Report Multi Asset Indices Selection and Rebalance Dates The report is designed to provide the details of future dates of selection and rebalance of various Multi-Asset

More information

EQUITY RESEARCH. OSFI releases draft of revisions to B-20 mortgage guidelines. For Required Non-U.S. Analyst and Conflicts Disclosures, see page 3.

EQUITY RESEARCH. OSFI releases draft of revisions to B-20 mortgage guidelines. For Required Non-U.S. Analyst and Conflicts Disclosures, see page 3. EQUITY RESEARCH July 7, 2017 Canadian Mortgage Industry OSFI releases draft of revisions to B-20 mortgage guidelines RBC Global Equity Team Click here for contributing analysts' contact information OSFI

More information

ANZ-ROY MORGAN AUSTRALIAN CONSUMER CONFIDENCE MEDIA RELEASE. Weekly change, % Four-week average Budget. Budget. Budget. Budget.

ANZ-ROY MORGAN AUSTRALIAN CONSUMER CONFIDENCE MEDIA RELEASE. Weekly change, % Four-week average Budget. Budget. Budget. Budget. Index ANZ RESEARCH ANZ-ROY MORGAN AUSTRALIAN CONSUMER CONFIDENCE MEDIA RELEASE 29 MAY 2018 CONTACT research@anz.com CONTRIBUTORS Mustafa Arif Junior Economist +91 80 6795 3801 mustafa.arif@anz.com David

More information

Q4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy

Q4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy 23-Apr-14 14-May-14 4-Jun-14 25-Jun-14 16-Jul-14 6-Aug-14 27-Aug-14 17-Sep-14 8-Oct-14 29-Oct-14 19-Nov-14 10-Dec-14 31-Dec-14 21-Jan-15 11-Feb-15 4-Mar-15 25-Mar-15 15-Apr-15 Daily Volume ('000) Share

More information

Multi Asset Indices Selection and Rebalance Dates

Multi Asset Indices Selection and Rebalance Dates 30 Jan 2017 DBIQ Index Selection Report Multi Asset Indices Selection and Rebalance Dates The report is designed to provide the details of future selection and rebalance dates of various Multi-Asset Indices

More information

Canadian Equity Strategy

Canadian Equity Strategy INVESTMENT STRATEGY I RESEARCH Canadian Equity Strategy The U.S. Election Oct-16 RBC Dominion Securities Inc. Matthew Barasch (Chief Canadian Equity Strategist) (416) 842-7857 matt.barasch@rbccm.com This

More information

Nestlé India Outlook Hazy; Valuations Prohibitive

Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India s net sales, EBITDA and net profit surged by 35% yoy, 67% yoy & 116% yoy to Rs23.5bn, Rs4.5bn & Rs2.7bn, respectively in 3QCY16. This growth

More information

U.S. EQUITIES: VALUATION & FUNDAMENTALS

U.S. EQUITIES: VALUATION & FUNDAMENTALS LM Market Insight: U.S. EQUITIES: VALUATION & FUNDAMENTALS DEC 2015 THIS MATERIAL IS ONLY FOR DISTRIBUTION IN THOSE COUNTRIES AND TO THOSE RECIPIENTS LISTED. PLEASE REFER TO THE DISCLOSURE INFORMATION

More information

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74 Equity Research Winner of next 5 years, BUY 2017 result: slow growth, but high profitability Revenue slightly improved by 8.5% YoY to HKD 118.5 bn. Thanks to GPM growing by 6.5 pts to 40%, gross profit

More information

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630 1QFY18 Result Update July 28,2017 CMP* (Rs) 208 Bloomberg Ticker CROMPTON IN Market Cap. (Rs bn) 130.6 Free Float (%) 65.6 Shares O/S (mn) 630 Channel De-stocking Impairs Top-line; Recovery Ahead Crompton

More information

Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research Premium valuations to sustain, Accumulate October 4, 17 Amnish Aggarwal amnishaggarwal@plindia.com +91 Gaurav Jogani gauravjogani@plindia.com +91 8 Rating Accumulate Price Rs1,1 Target Price Rs1,9 Implied

More information

Jefferies Group Another Hack Attack

Jefferies Group Another Hack Attack EQUITY RESEARCH COMPANY UPDATE November 23, 2011 Stock Rating: PERFORM 12-18 mo. Price Target NA JEF - NYSE $10.06 3- Yr. EPS Gr. Rate NA 2-Wk Range $27.12-$9.0 Shares Outstanding 199.7M Float 148.3M Market

More information

Technical Analysis: Market Insight

Technical Analysis: Market Insight Technical Analysis: Market Insight October 1987 vs. October 2017 Today (Oct. 19, 2017) marks the 30 th anniversary of Black Monday a global market crash during which the S&P 500 dropped 20% in one day.

More information

MGIC Investment Corporation

MGIC Investment Corporation Upsi de 25.1% 09-Mar-2015, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A Equity Research October 15, 2015 Mark Palmer (212) 588-6582 mpalmer@btig.com Giuliano

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

INDEX PERFORMANCE HISTORY MARKET CYCLE ANALYSIS*

INDEX PERFORMANCE HISTORY MARKET CYCLE ANALYSIS* OVERVIEW Index Name: Helios Alpha Index Ticker: Inception Date: September 30, 2003 S&P Launch Date: March 3, 2017 Benchmark: MSCI ACWI Index INDEX PERFORMANCE HISTORY As of: October 31, 2018 DESCRIPTION

More information

View from the market Jahangir Aziz

View from the market Jahangir Aziz S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L View from the market Jahangir Aziz 202-585-1254 jahangir.x.aziz@jpmorgan.com Mar-09 Aug-09 Dec-09 May-10 Oct-10 Mar-11 Aug-11 Jan-12 INR: India

More information

INDEX PERFORMANCE HISTORY MARKET CYCLE ANALYSIS*

INDEX PERFORMANCE HISTORY MARKET CYCLE ANALYSIS* Jun 09 Dec 09 Jun 10 Dec 10 Jun 11 Dec 11 Jun 12 Dec 12 Jun 13 Dec 13 Jun 14 Dec 14 Jun 15 Dec 15 Jun 16 Dec 16 Jun 17 Dec 17 Jun 18 Dec 18 Dec 07 Jan 08 Feb 08 Mar 08 Apr 08 May 08 Jun 08 Jul 08 Aug 08

More information

Gaming / Lodging Sector

Gaming / Lodging Sector Gaming / Lodging Sector Fortune Favors the Prepared Into the Golden Week October 3, 16 Macau Gaming Sector Bloomberg Price change (%) Code 1/09/16 MTD QTD YTD 1928 HK (6) 10 30 27 27 HK (3) 16 27 19 1128

More information

The Compelling Case for Value

The Compelling Case for Value The Compelling Case for Value July 2, 2018 SOLELY FOR THE USE OF INSTITUTIONAL INVESTORS AND PROFESSIONAL ADVISORS 0 Jan-75 Jan-77 Jan-79 Jan-81 Jan-83 Jan-85 Jan-87 Jan-89 Jan-91 Jan-93 Jan-95 Jan-97

More information

FIRST GLANCE COMMENT. Enbridge Inc. (TSX: ENB; 36.69; NYSE: ENB) Q1/07 Results Generally In Line. Sector Perform Average Risk. Impact Neutral.

FIRST GLANCE COMMENT. Enbridge Inc. (TSX: ENB; 36.69; NYSE: ENB) Q1/07 Results Generally In Line. Sector Perform Average Risk. Impact Neutral. 125 WEEKS 17DEC04-01MAY07 Rel. S&P/TSX COMPOSITE INDEX HI-20MAY05 110.97 110.00 HI/LO DIFF -24.90% 100.00 90.00 40.00 38.00 36.00 34.00 32.00 30.00 28.00 7500 6000 4500 3000 1500 2005 D J F M A M J J A

More information

INDEX PERFORMANCE HISTORY MARKET CYCLE ANALYSIS*

INDEX PERFORMANCE HISTORY MARKET CYCLE ANALYSIS* OVERVIEW Index Name: Helios Diversified Index Ticker: Inception Date: September 30, 2003 S&P Launch Date: March 3, 2017 : 45% MSCI ACWI / 25% BBgBarc Agg Bond / 30% Morningstar Div Alts Morningstar SecID:

More information

US Rates Outlook: The Fed s Third Mandate

US Rates Outlook: The Fed s Third Mandate US Rates Outlook: The Fed s Third Mandate April 2016 Gennadiy Goldberg US Rates Strategist gennadiy.goldberg@tdsecurities.com 1 (212) 827-7180 Lopsided employment picture rapidly improving 2 Wage inflation:

More information

INDEX PERFORMANCE HISTORY MARKET CYCLE ANALYSIS*

INDEX PERFORMANCE HISTORY MARKET CYCLE ANALYSIS* OVERVIEW Index Name: Helios Dynamic Risk 13% Index Ticker: Inception Date: February 28, 2005 S&P Launch Date: March 3, 2017 Benchmark: 65% MSCI ACWI / 35% BBgBarc Agg Bond Morningstar SecID: F00000YYHJ

More information

SAFCO Q3: Margin beat as Urea price increases

SAFCO Q3: Margin beat as Urea price increases Vol mn RSI10 Petrochemicals Industrial AB: Saudi Arabia US$9.01bn 40% US$8.28mn Market cap Free float Avg. daily volume Target price 85.00 +4.8% over current Current price 81.10 as at 30/10/2018 Underweight

More information

City of London Investment Group*

City of London Investment Group* For FCA purposes this is a Marketing Communication City of London Investment Group* CLIG LN Tough 1H trading update Financials What s new. CLIG s 1H trading update released this morning reveals details

More information

Nanosonics Limited. Strong start to FY16

Nanosonics Limited. Strong start to FY16 Biomedical Devices and Services Australian Equity Research 30 October 2015 BUY unchanged PRICE TARGET unchanged Price (30-Oct) Ticker A$1.95 A$1.64 NAN-ASX 52-Week Range (A$): 0.94-2.02 Avg Daily Vol (000s)

More information

AUSTRALIAN SECURITISATION FORUM Australian Market Review and Outlook. Ken Hanton May 2018

AUSTRALIAN SECURITISATION FORUM Australian Market Review and Outlook. Ken Hanton May 2018 AUSTRALIAN SECURITISATION FORUM Australian Market Review and Outlook Ken Hanton May 2018 Australian Bond Market Source: Australian Fixed Income Securities in a Low Rate World. Christopher Kent, RBA, Assistant

More information

Presentation Global private equity trends

Presentation Global private equity trends Presentation Global private equity trends Alex Scott Partner Pantheon Ventures Global Private Equity Trends Alex Scott July 2018 Hitting the headlines IPOS ARE DWINDLING, SO IS THE NUMBER OF PUBLIC COMPANIES

More information

CONSENSUS OPERATING EARNINGS for the S&P 500, MidCap 400 and SmallCap 600 Indices, as well as the Sectors in the S&P /02/18

CONSENSUS OPERATING EARNINGS for the S&P 500, MidCap 400 and SmallCap 600 Indices, as well as the Sectors in the S&P /02/18 CONSENSUS OPERATING EARNINGS for the S&P 500, MidCap 400 and SmallCap 600 Indices, as well as the Sectors in the S&P 500. 02/02/18 Operating EPS Y/Y % chgs. S&P 500 Sector Q1 Q2 2017 Q3 Q4E Year Q1E Q2E

More information

Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research Premium Valuations to sustain, Accumulate May, 17 Amnish Aggarwal amnishaggarwal@plindia.com +91 Gaurav Jogani gauravjogani@plindia.com +91 8 Rating Accumulate Price Rs1,18 Target Price Rs1,171 Implied

More information

Figure 1 SAFCO Q1 results Q Q Q (SAR mn) Operating profit % 375.6% 347. Operating margin 47% 8% 30% 40%

Figure 1 SAFCO Q1 results Q Q Q (SAR mn) Operating profit % 375.6% 347. Operating margin 47% 8% 30% 40% Vol mn RSI10 SAFCO Petrochemicals Industrial SAFCO AB: Saudi Arabia US$7.22bn 40% US$5.60mn Market cap Free float Avg. daily volume Target price 62.00-2.6% over current Current price 63.70 as at 8/5/2018

More information

ANZ-Roy Morgan NZ Consumer Confidence

ANZ-Roy Morgan NZ Consumer Confidence ANZ Research ANZ-Roy Morgan NZ Consumer Confidence 1 February 219 This is not personal advice. It does not consider your objectives or circumstances. Please refer to the Important Notice. Pretty happy

More information

FLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target 6.40 Price Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook

FLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target 6.40 Price Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook ELANIX BIOTECHNOLOGIES AG Biotechnology 8 August 2018 09:54 BST FLASH NOTE Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook OUTPERFORM Price target 6.40 Price 2.72 KEY

More information